Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Visual and Anatomical Outcomes of Endogenous Klebsiella pneumoniae Endophthalmitis with and without Vitrectomy: A Systemic Review and Meta-analysis of Individual Participant Data
Author Affiliations & Notes
  • Chieh-Yu Lin
    Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
  • Wen-Yi Shau
    Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
  • Chia-Ying Tsai
    Department of Ophthalmology, Fu Jen Catholic University Hospital, New Taipei City, Taiwan
    School of Medicine, Fu Jen Catholic University College of Medicine, New Taipei City, Taiwan
  • Tso-Ting Lai
    Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
  • Footnotes
    Commercial Relationships   Chieh-Yu Lin None; Wen-Yi Shau None; Chia-Ying Tsai None; Tso-Ting Lai None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 772. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chieh-Yu Lin, Wen-Yi Shau, Chia-Ying Tsai, Tso-Ting Lai; Visual and Anatomical Outcomes of Endogenous Klebsiella pneumoniae Endophthalmitis with and without Vitrectomy: A Systemic Review and Meta-analysis of Individual Participant Data. Invest. Ophthalmol. Vis. Sci. 2024;65(7):772.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The use of vitrectomy in endogenous Klebsiella pneumoniae endophthalmitis (EKPE) is controversial due to the rarity of EKPE and the lack of trials. We aimed to compare outcomes in EKPE patients with and without vitrectomy by combining existing individual data using meta-analysis.

Methods : PubMed, Embase, and Web of Science were searched from inception until December 31, 2021. The eligibility criteria were: (1) enrolled patients with EKPE, (2) included either vitrectomy, intravitreal injection (IVI) of antibiotics, or both as interventions, and (3) reported both initial and final visual acuities (VAs). VAs were converted to the logarithm of the minimum angle of resolution. Poor VA was defined as hand motion or worse. Main outcomes included the mean differences (MDs) of the VA change and the odds ratios (ORs) of poor final VA and anatomical failure between eyes that underwent vitrectomy (the vitrectomy group) and those that received IVI antibiotics alone (the non-vitrectomy group). During meta-analysis, studies were classified into within-study comparisons (WSCs) and single-arm studies (SASs); the former underwent analysis with the generalized linear mixed model, and the latter with generalized estimating equations. A secondary meta-analysis integrated effect estimates through a fixed-effect model. Quality of the evidence was accessed with the Grading of Recommendations Assessment, Development and Evaluation.

Results : From the 68 retrospective studies included, 324 patients with 383 affected eyes were reported. Overall, the mean initial VA was 2.121 ± 0.750 and the mean final VA was 2.223 ± 0.988. The mean VA change was significantly better in the vitrectomy group (MD = -0.27; 95% CI = -0.40 to -0.14; P < 0.01). In preset subgroup analysis based on initial VA, the result stayed robust in eyes with poor initial VA (MD = -0.35; 95% CI = -0.49 to -0.21; P < 0.01). There were no significant differences in risk of poor final VA (OR = 0.84; 95% CI = 0.40 to 1.75; P = 0.64) and risk of anatomical failure (OR = 0.42; 95% CI = 0.15 to 1.13; P = 0.09) between the two groups. The quality of the evidence was very low mainly due to the lack of randomized controlled trials.

Conclusions : Vitrectomy resulted in greater VA improvement compared to IVI antibiotics alone in eyes with EKPE, especially in those with poor initial VA.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×